Diabetic Muscular Atrophy: Molecular Mechanisms and Promising Therapies

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2022 Jul 18

PMID 35846289

Authors

Yuntian Shen

Ming Li

Kexin Wang

Guangdong Qi

Hua Liu

Wei Wang

Yanan Ji

Mengyuan Chang

Chunyan Deng

Feng Xu

Mi Shen

Hualin Sun

Affiliations

Soon will be listed here.

Abstract

Diabetes mellitus (DM) is a typical chronic disease that can be divided into 2 types, dependent on insulin deficiency or insulin resistance. Incidences of diabetic complications gradually increase as the disease progresses. Studies in diabetes complications have mostly focused on kidney and cardiovascular diseases, as well as neuropathy. However, DM can also cause skeletal muscle atrophy. Diabetic muscular atrophy is an unrecognized diabetic complication that can lead to quadriplegia in severe cases, seriously impacting patients' quality of life. In this review, we first identify the main molecular mechanisms of muscle atrophy from the aspects of protein degradation and synthesis signaling pathways. Then, we discuss the molecular regulatory mechanisms of diabetic muscular atrophy, and outline potential drugs and treatments in terms of insulin resistance, insulin deficiency, inflammation, oxidative stress, glucocorticoids, and other factors. It is worth noting that inflammation and oxidative stress are closely related to insulin resistance and insulin deficiency in diabetic muscular atrophy. Regulating inflammation and oxidative stress may represent another very important way to treat diabetic muscular atrophy, in addition to controlling insulin signaling. Understanding the molecular regulatory mechanism of diabetic muscular atrophy could help to reveal new treatment strategies.

Citing Articles

Stem cell therapy: A promising therapeutic approach for skeletal muscle atrophy.

Wang Y, Chen Z, Shen Y, Wang K, Han Y, Zhang C World J Stem Cells. 2025; 17(2):98693.

PMID: 40061264 PMC: 11885941. DOI: 10.4252/wjsc.v17.i2.98693.

hBMSC-EVs alleviate weightlessness-induced skeletal muscle atrophy by suppressing oxidative stress and inflammation.

Chang M, Liu R, Chen B, Xu J, Wang W, Ji Y Stem Cell Res Ther. 2025; 16(1):46.

PMID: 39901193 PMC: 11792267. DOI: 10.1186/s13287-025-04175-y.

Loss or inhibition of lysosomal acid lipase leads to cholesteryl ester accumulation without affecting muscle formation or mitochondrial function.

Akhmetshina A, Schooltink L, Amor M, Kuentzel K, Rainer S, Nandy A BBA Adv. 2025; 7():100135.

PMID: 39839442 PMC: 11745973. DOI: 10.1016/j.bbadva.2024.100135.

Therapeutic potential of 4-hexylresorcinol in reducing sarcopenia in diabetic masseter muscle.

Gaida D, Park Y, Kang Y, Kim S Maxillofac Plast Reconstr Surg. 2025; 47(1):2.

PMID: 39832033 PMC: 11747031. DOI: 10.1186/s40902-025-00457-w.

Delayed Tooth Development and the Impaired Differentiation of Stem/Progenitor Cells in Incisors from Type 2 Diabetes Mice.

Kobayashi Y, Huang J, Barnett B, Falcon C, Falcon P, Hirschberg C Int J Mol Sci. 2025; 25(24.

PMID: 39769381 PMC: 11728242. DOI: 10.3390/ijms252413619.

References

Perry B, Caldow M, Brennan-Speranza T, Sbaraglia M, Jerums G, Garnham A . Muscle atrophy in patients with Type 2 Diabetes Mellitus: roles of inflammatory pathways, physical activity and exercise. Exerc Immunol Rev. 2016; 22:94-109. PMC: 5545118. View

Chang J, Choi M . A Molecular Perspective on the Potential Benefits of Metformin for the Treatment of Inflammatory Skin Disorders. Int J Mol Sci. 2020; 21(23). PMC: 7728327. DOI: 10.3390/ijms21238960. View

Yakubu A, Azlan A, Loh S, Md Noor S . Can Yellow Stripe Scad Compete with Salmon on Its Role in Platelet Phospholipid Membrane and Its Cardiovascular Benefits?. J Obes. 2019; 2019:4929131. PMC: 6636454. DOI: 10.1155/2019/4929131. View

Goncalves D, Silveira W, Manfredi L, Graca F, Armani A, Bertaggia E . Insulin/IGF1 signalling mediates the effects of β -adrenergic agonist on muscle proteostasis and growth. J Cachexia Sarcopenia Muscle. 2019; 10(2):455-475. PMC: 6463755. DOI: 10.1002/jcsm.12395. View

Nikawa T, Ulla A, Sakakibara I . Polyphenols and Their Effects on Muscle Atrophy and Muscle Health. Molecules. 2021; 26(16). PMC: 8398525. DOI: 10.3390/molecules26164887. View

Wang M, Tan Y, Shi Y, Wang X, Liao Z, Wei P . Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments. Front Endocrinol (Lausanne). 2020; 11:568. PMC: 7477770. DOI: 10.3389/fendo.2020.00568. View

Zhang L, Pan J, Dong Y, Tweardy D, Dong Y, Garibotto G . Stat3 activation links a C/EBPδ to myostatin pathway to stimulate loss of muscle mass. Cell Metab. 2013; 18(3):368-79. PMC: 3794464. DOI: 10.1016/j.cmet.2013.07.012. View

Yadav A, Singh A, Phogat J, Dahuja A, Dabur R . Magnoflorine prevent the skeletal muscle atrophy via Akt/mTOR/FoxO signal pathway and increase slow-MyHC production in streptozotocin-induced diabetic rats. J Ethnopharmacol. 2020; 267:113510. DOI: 10.1016/j.jep.2020.113510. View

Jang S, Redon C, Thakur B, Bahta M, Aladjem M . Regulation of cell cycle drivers by Cullin-RING ubiquitin ligases. Exp Mol Med. 2020; 52(10):1637-1651. PMC: 8080560. DOI: 10.1038/s12276-020-00508-4. View

10.

Sharma V, Singh T . Chronic Stress and Diabetes Mellitus: Interwoven Pathologies. Curr Diabetes Rev. 2019; 16(6):546-556. DOI: 10.2174/1573399815666191111152248. View

11.

Pohl C, Dikic I . Cellular quality control by the ubiquitin-proteasome system and autophagy. Science. 2019; 366(6467):818-822. DOI: 10.1126/science.aax3769. View

12.

Hain B, Xu H, Waning D . Loss of REDD1 prevents chemotherapy-induced muscle atrophy and weakness in mice. J Cachexia Sarcopenia Muscle. 2021; 12(6):1597-1612. PMC: 8718092. DOI: 10.1002/jcsm.12795. View

13.

Takashima M, Ogawa W, Hayashi K, Inoue H, Kinoshita S, Okamoto Y . Role of KLF15 in regulation of hepatic gluconeogenesis and metformin action. Diabetes. 2010; 59(7):1608-15. PMC: 2889759. DOI: 10.2337/db09-1679. View

14.

Thoma A, Lightfoot A . NF-kB and Inflammatory Cytokine Signalling: Role in Skeletal Muscle Atrophy. Adv Exp Med Biol. 2018; 1088:267-279. DOI: 10.1007/978-981-13-1435-3_12. View

15.

Chen S, Villalta S, Agrawal D . FOXO1 Mediates Vitamin D Deficiency-Induced Insulin Resistance in Skeletal Muscle. J Bone Miner Res. 2015; 31(3):585-95. PMC: 4814301. DOI: 10.1002/jbmr.2729. View

16.

Wang Y, Le W . Autophagy and Ubiquitin-Proteasome System. Adv Exp Med Biol. 2019; 1206:527-550. DOI: 10.1007/978-981-15-0602-4_25. View

17.

Peixoto L, Teixeira R, Vilela D, Barbosa L, Caixeta D, Deconte S . Metformin attenuates the TLR4 inflammatory pathway in skeletal muscle of diabetic rats. Acta Diabetol. 2017; 54(10):943-951. DOI: 10.1007/s00592-017-1027-5. View

18.

Hirata Y, Nomura K, Senga Y, Okada Y, Kobayashi K, Okamoto S . Hyperglycemia induces skeletal muscle atrophy via a WWP1/KLF15 axis. JCI Insight. 2019; 4(4). PMC: 6478420. DOI: 10.1172/jci.insight.124952. View

19.

Mukund K, Subramaniam S . Skeletal muscle: A review of molecular structure and function, in health and disease. Wiley Interdiscip Rev Syst Biol Med. 2019; 12(1):e1462. PMC: 6916202. DOI: 10.1002/wsbm.1462. View

20.

DiNicolantonio J, OKeefe J . Importance of maintaining a low omega-6/omega-3 ratio for reducing inflammation. Open Heart. 2018; 5(2):e000946. PMC: 6269634. DOI: 10.1136/openhrt-2018-000946. View